Rockwell Medical Technologies Inc.
30142 Wixom Road
Wixom,
MI 48393
United States - Map
Phone: 248-960-9009
Fax: 248-960-9119
Web Site: http://www.rockwellmed.com
| Rockwell Medical Technologies, Inc., an integrated biopharmaceutical company, offers products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia. It offers products that are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. The company is developing proprietary renal drug therapies for iron treatment. These exclusive renal drug therapies support disease management initiatives to improve the quality of life and care of dialysis patients and are designed to deliver safe and effective therapy, while decreasing drug administration costs and improving patient convenience. Rockwell is developing a pipeline of drug therapies, including extensions of SFP for indications outside of hemodialysis. The company produces acidified concentrate solutions and powders, and bicarbonate concentrate solutions and powders for nationwide distribution, as well as offers blood tubing sets, fistula needles, and a range of ancillary products. It markets its products through direct sales people, independent sales representation companies and agents, and distributors in the United States, Latin America, Asia, and Europe. The company was founded in 1995 and is based in Wixom, Michigan. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Robert L. Chioini , 44
Founder, Chairman, Chief Exec. Officer, Pres and Member of Stock Option Committee |
N/A
| N/A | Mr. Thomas E. Klema , 55
Chief Financial Officer, Principal Accounting Officer, VP of Fin., Sec. and Treasurer |
N/A
| N/A | Dr. Ajay Gupta MD,
Chief Scientific Officer and Member of Scientific Advisory Board |
N/A
| N/A | Dr. Richard C. Yocum M.D., 53
VP of Drug Devel. & Medical Affairs |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
2.03% Nasdaq 
Profile
